Literature DB >> 15271502

Copper(II) Schiff base coordination compounds of dien with heterocyclic aldehydes and 2-amino-5-methyl-thiazole: synthesis, characterization, antiproliferative and antibacterial studies. Crystal structure of CudienOOCl2.

A Th Chaviara1, P J Cox, K H Repana, R M Papi, K T Papazisis, D Zambouli, A H Kortsaris, D A Kyriakidis, C A Bolos.   

Abstract

A new series of coordination compounds of the starting materials [Cu(dienX(2)Y(2))] and their adducts [Cu(dienXXY(2))(2a-5mt)] (where dien=diethylenetriamine, dienXX=Schiff bases of diethylenetriamine with 2-furaldehyde or 2-thiophene-carboxaldehyde, X=O, S, Y=Cl, Br, NO(3) and 2a-5mt=2-amino-5-methylthiazole) were synthesized by stepwise reactions and their structures were established by C, H, N, Cu analysis, spectroscopic, magnetic and molar conductivity measurements. The isolated compounds are monomers, paramagnetic and electrolytic compounds of the type 1:1. In all cases, the pentadentate Schiff base (dienXX) is bonded in a tridentate fashion through the 3 N atoms. In the CudienXXY(2) compounds the coordination sphere is completed by two Cl or Br or NO(3) groups in a square pyramidal arrangement. The proposed structure for this type of compound was further supported by X-ray diffraction analysis of the compound [Cu(dienOO)Cl(2)]. Its basal plane consists of three Cu-N contacts [2.017(2), 2.025(2) and 2.012(2) A] from dienOO, and the Cl(1) atom, while the Cl(2) atom possesses the apical position, the relevant distances being 2.2732(7) A for Cu-Cl(1) and 2.6051(7) A Cu-Cl(2). In the CudienX(2)Y(2).2a-5mt adducts the coordination sphere of copper is further completed by the nitrogen ring atom of the 2a-5mt, forming an octahedral configuration. The study of the biological activity of the compounds synthesized against a panel of different normal and cancer cell lines (MRC5, HeLa, MCF7, HT-29, OAW42, T47D) and bacteria (E. coli, B. cereus, B. subtilis) showed that the adducts of the type [Cu(dienXXY(2))(2a-5mt)] exhibit increased activity both in cancer cells and in bacteria, compared to the starting material of type [Cu(dienXXY(2))].

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271502     DOI: 10.1016/j.jinorgbio.2004.05.010

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

1.  Thermodynamics, conformation and active sites of the binding of Zn-Nd hetero-bimetallic Schiff base to bovine serum albumin.

Authors:  Qi Xiao; Shan Huang; Yi Liu; Fang-fang Tian; Jun-cheng Zhu
Journal:  J Fluoresc       Date:  2008-10-21       Impact factor: 2.217

2.  Synthesis of new Schiff bases bearing 1,2,4-triazole, thiazolidine and chloroazetidine moieties and their pharmacological evaluation.

Authors:  Nadia G Kandile; Mansoura I Mohamed; Hind M Ismaeel
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-21       Impact factor: 5.051

3.  A new Schiff base coordinated copper(II) compound induces apoptosis and inhibits tumor growth in gastric cancer.

Authors:  Yan Xia; Xingkai Liu; Luping Zhang; Jinzhu Zhang; Chaoying Li; Nan Zhang; Hong Xu; Yan Li
Journal:  Cancer Cell Int       Date:  2019-04-03       Impact factor: 5.722

4.  Synthesis and physicochemical, DFT, thermal and DNA-binding analysis of a new pentadentate N3S2 Schiff base ligand and its [CuN3S2]2+ complexes.

Authors:  Ismail Warad; Hadeel Suboh; Nabil Al-Zaqri; Ali Alsalme; Fahad A Alharthi; Meshari M Aljohani; Abdelkader Zarrouk
Journal:  RSC Adv       Date:  2020-06-10       Impact factor: 4.036

5.  TBHP-mediated oxidative synthesis of substituted pyrimido[4,5-d]pyrimidines from N-uracil amidines and methylarenes under metal free conditions.

Authors:  Pradip Debnath
Journal:  RSC Adv       Date:  2019-09-20       Impact factor: 4.036

6.  A Schiff base-derived copper (II) complex is a potent inducer of apoptosis in colon cancer cells by activating the intrinsic pathway.

Authors:  Maryam Hajrezaie; Mohammadjavad Paydar; Soheil Zorofchian Moghadamtousi; Pouya Hassandarvish; Nura Suleiman Gwaram; Maryam Zahedifard; Elham Rouhollahi; Hamed Karimian; Chung Yeng Looi; Hapipah Mohd Ali; Nazia Abdul Majid; Mahmood Ameen Abdulla
Journal:  ScientificWorldJournal       Date:  2014-03-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.